- Home
- PTGX vs NHI Comparison
PTGX vs NHI Comparison
Compare PTGX & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- NHI
- Stock Information
- Founded
- PTGX 2006
- NHI 1991
- Country
- PTGX United States
- NHI United States
- Employees
- PTGX N/A
- NHI N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- NHI Real Estate Investment Trusts
- Sector
- PTGX Health Care
- NHI Real Estate
- Exchange
- PTGX Nasdaq
- NHI Nasdaq
- Market Cap
- PTGX 5.0B
- NHI 3.7B
- IPO Year
- PTGX 2016
- NHI 1991
- Fundamental
- Price
- PTGX $83.89
- NHI $76.97
- Analyst Decision
- PTGX Strong Buy
- NHI Buy
- Analyst Count
- PTGX 9
- NHI 4
- Target Price
- PTGX $86.22
- NHI $82.75
- AVG Volume (30 Days)
- PTGX 998.7K
- NHI 202.5K
- Earning Date
- PTGX 11-06-2025
- NHI 11-06-2025
- Dividend Yield
- PTGX N/A
- NHI 4.76%
- EPS Growth
- PTGX N/A
- NHI 8.88
- EPS
- PTGX 0.72
- NHI 3.17
- Revenue
- PTGX $209,217,000.00
- NHI $357,572,000.00
- Revenue This Year
- PTGX N/A
- NHI $4.68
- Revenue Next Year
- PTGX $140.23
- NHI $10.60
- P/E Ratio
- PTGX $115.56
- NHI $24.38
- Revenue Growth
- PTGX N/A
- NHI 8.40
- 52 Week Low
- PTGX $33.31
- NHI $65.13
- 52 Week High
- PTGX $93.25
- NHI $82.32
- Technical
- Relative Strength Index (RSI)
- PTGX 68.79
- NHI 56.55
- Support Level
- PTGX $76.70
- NHI $74.87
- Resistance Level
- PTGX $80.43
- NHI $77.88
- Average True Range (ATR)
- PTGX 2.82
- NHI 1.79
- MACD
- PTGX 0.11
- NHI 0.30
- Stochastic Oscillator
- PTGX 98.00
- NHI 81.32
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About NHI National Health Investors Inc.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.